Cargando…
Metformin therapy as a strategy to compensate anti-VEGF resistance in patients with diabetic macular edema
Diabetic macular edema (DME) is the complication of diabetic retinopathy, the leading cause of vision loss among diabetic patients. Metformin is the main antidiabetic treatment. It is preferable for its great anti-angiogenic and anti-inflammatory effects. Anti-vascular endothelial growth factor (VEG...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9592524/ https://www.ncbi.nlm.nih.gov/pubmed/36281139 http://dx.doi.org/10.1097/MD.0000000000031266 |